C

Can Fite Biopharma Ltd
TASE:CANF

Watchlist Manager
Can Fite Biopharma Ltd
TASE:CANF
Watchlist
Price: 708.8 ILS 1.26% Market Closed
Market Cap: ₪18.2m

Wall Street
Price Targets

CANF Price Targets Summary
Can Fite Biopharma Ltd

There are no price targets for CANF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Can Fite Biopharma Ltd Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
140% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
2% / Year
Past Growth
140% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Can Fite Biopharma Ltd's revenue is 2%. The projected CAGR for the next 3 years is 140%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CANF's stock price target?
Not Available

CANF doesn't have any price targets made by Wall Street professionals.

What is Can Fite Biopharma Ltd's Revenue forecast?
Projected CAGR
140%

For the last 13 years the compound annual growth rate for Can Fite Biopharma Ltd's revenue is 2%. The projected CAGR for the next 3 years is 140%.

Back to Top